Aglagmed Llc Pharmaceutical Import Profile — Mongolia (DGFT 2022–2026)

Name: Aglagmed Llc Pharmaceutical Import Records from India — 2 Products, $362.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Aglagmed Llc — Pharmaceutical Importer Profile (2026) | 2 Products, $362.6K Trade | TransData Nexus

Aglagmed Llc

Pharmaceutical Importer · Mongolia · Medical Devices & Diagnostics Focus · $362.6K Total Trade · DGFT Verified

Aglagmed Llc is a pharmaceutical importer based in Mongolia with a total trade value of $362.6K across 2 products in 1 therapeutic categories. Based on 14 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Aglagmed Llc sources from 1 verified Indian supplier, with Arkray Healthcare Private Limited accounting for 100.0% of imports.

Aglagmed Llc — Import Portfolio & Supplier Network

Aglagmed Llc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Aglagmed Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Arkray Healthcare Private Limited	$181.3K	7	100.0%

Aglagmed Llc sources from 1 verified Indian supplier across 3 distinct formulations. The sourcing is highly concentrated — Arkray Healthcare Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Aglagmed Llc Import?

Formulation	Value	Ships
Diagnostic kits laboratory	$152.3K	5
Diagnostics kits (laboratory reagents) -tuberculin ppd 2tu/0.1ML (Pack size: 1ML)	$15.3K	1
Diagnostic kits laboratory reagents tiberculin ppd 2tu 0 1 ML Pack size 1 ML batch no 4000031925 exp july	$13.7K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Diagnostic	Medical Devices & Diagnostics	$181.3K	7	1.0%	14
2	Reagent	Medical Devices & Diagnostics	$181.3K	7	1.4%	12

Aglagmed Llc imports 2 pharmaceutical products across 1 categories into Mongolia totaling $362.6K.

Aglagmed Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Aglagmed LLC is a pharmaceutical importer and buyer based in Ulaanbaatar, Mongolia. The company specializes in importing finished pharmaceutical formulations, including diagnostic kits and laboratory reagents, primarily from India. Over the period from 2022 to 2026, Aglagmed LLC has imported a total of $363,000 USD worth of products, comprising 14 shipments. The company's portfolio is concentrated in the Medical Devices & Diagnostics category, with a 100% share in this segment. Notably, Aglagmed LLC's top five products, including diagnostic kits and reagents, account for the entire import value, indicating a focused product strategy. The sole verified Indian supplier, ARKRAY Healthcare Private Limited, has been the exclusive source for these imports, supplying all 14 shipments valued at $181,000 USD. This exclusive sourcing arrangement suggests a strategic partnership or a reliance on a single supplier for these specific product categories.

2Distribution Network

Specific details regarding Aglagmed LLC's warehouse locations and logistics capabilities are not publicly available. However, given the company's import activities, it is likely that they maintain a distribution network within Mongolia to supply diagnostic kits and laboratory reagents to healthcare facilities, pharmacies, and laboratories. The geographic coverage of their distribution network would encompass major urban centers, including Ulaanbaatar, and potentially extend to regional hospitals and clinics across the country. The company's logistics operations would need to ensure timely and efficient delivery of temperature-sensitive medical products, adhering to the storage and transportation requirements mandated by Mongolian regulations.

3Industry Role

Aglagmed LLC functions as a pharmaceutical importer and distributor within Mongolia's healthcare supply chain. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company plays a crucial role in ensuring the availability of essential diagnostic tools and reagents in the Mongolian market. Their focus on importing specific product categories indicates a specialized role in supplying medical devices and diagnostics, catering to the needs of healthcare providers and laboratories across the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Aglagmed Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Aglagmed LLC's sourcing strategy exhibits a high degree of concentration, with all 14 shipments valued at $181,000 USD sourced exclusively from ARKRAY Healthcare Private Limited in India. This single-source dependency could pose risks related to supply chain disruptions, such as production delays, quality control issues, or geopolitical factors affecting trade relations. The absence of alternative suppliers for these specific products suggests a strategic choice to maintain consistency and quality in their product offerings. However, this reliance also underscores the importance of a robust and resilient relationship with ARKRAY Healthcare Private Limited to mitigate potential supply chain vulnerabilities.

2Supply Chain Resilience

The resilience of Aglagmed LLC's supply chain is closely tied to its exclusive partnership with ARKRAY Healthcare Private Limited. While this arrangement ensures product consistency, it also means that any disruptions affecting ARKRAY's production or export capabilities could directly impact Aglagmed LLC's ability to meet market demand. The company's supply chain appears to lack diversification, with no backup suppliers identified for these product categories. Additionally, the shipping routes and regulatory compliance of ARKRAY Healthcare Private Limited are not detailed, making it challenging to assess the full resilience of the supply chain. To enhance supply chain robustness, Aglagmed LLC might consider exploring additional suppliers or establishing contingency plans to address potential disruptions.

Importing Pharmaceuticals into Mongolia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Mongolia

1Regulatory Authority & Framework

The pharmaceutical sector in Mongolia is regulated by the Ministry of Health, which oversees the import, export, storage, sale, and distribution of medicines and medical devices. The primary legislation governing these activities is the Law on Medicines and Medical Devices, which was revised and adopted by the Mongolian Parliament on June 5, 2024, and became effective on October 1, 2024. This revised law introduced significant changes to the pharmaceutical and medical sectors, including broader definitions and additional requirements for certain activities. The law mandates that entities involved in the import and export of medicines and medical devices obtain the necessary licenses from the relevant state administrative bodies responsible for pharmaceutical and agricultural aspects. Aglagmed LLC, as a pharmaceutical importer, is required to comply with these regulations to operate legally within Mongolia.

2Import Licensing & GMP

To import medicines and medical devices into Mongolia, companies like Aglagmed LLC must obtain an import-supply license from the state administrative bodies responsible for pharmaceutical and agricultural aspects. The import license documents must specify the names, types, doses, and quantities of the medicines and medical devices, as well as the names of manufacturers, frontier crossing points, and dates. Additionally, the Ministry of Health requires that imported pharmaceutical products comply with Good Manufacturing Practice (GMP) standards. While the specific GMP certifications recognized by Mongolian authorities are not detailed, it is generally expected that imported products adhere to internationally recognized GMP standards, such as those established by the World Health Organization (WHO) or the European Medicines Agency (EMA). Aglagmed LLC must ensure that its suppliers, including ARKRAY Healthcare Private Limited, meet these GMP requirements to facilitate the importation process.

Aglagmed Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Aglagmed LLC's product strategy focuses on importing diagnostic kits and laboratory reagents, specifically targeting the Medical Devices & Diagnostics category. This focus aligns with the growing demand for advanced diagnostic tools in Mongolia's healthcare sector, driven by the need for accurate and timely disease detection. The company's exclusive sourcing from ARKRAY Healthcare Private Limited suggests a strategic decision to ensure product quality and consistency. By concentrating on these specific product categories, Aglagmed LLC aims to meet the specialized needs of healthcare providers and laboratories, contributing to improved patient outcomes through enhanced diagnostic capabilities.

2Sourcing Profile

Aglagmed LLC's sourcing strategy is centered on importing finished pharmaceutical formulations, including diagnostic kits and laboratory reagents, from ARKRAY Healthcare Private Limited in India. This approach indicates a preference for high-quality, ready-to-use products that meet international standards. The company's focus on a single supplier suggests a desire for streamlined procurement processes and potentially favorable terms. However, this strategy also exposes Aglagmed LLC to risks associated with supply chain disruptions, underscoring the importance of maintaining a strong and reliable relationship with ARKRAY Healthcare Private Limited.

Market Positioning

Seller's Guide — How to Become a Supplier to Aglagmed Llc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Aglagmed LLC, given the company's exclusive sourcing from ARKRAY Healthcare Private Limited. Alternative suppliers could offer competitive pricing, product differentiation, or enhanced supply chain reliability to meet the growing demand for diagnostic kits and laboratory reagents in Mongolia. Establishing relationships with Aglagmed LLC could lead to increased market penetration in Mongolia's pharmaceutical sector, especially if new suppliers can demonstrate compliance with Mongolian regulatory standards and offer products

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Aglagmed Llc

What products does Aglagmed Llc import from India?

Aglagmed Llc imports 2 pharmaceutical products across 1 categories. Top imports: Diagnostic ($181.3K), Reagent ($181.3K).

Who supplies pharmaceuticals to Aglagmed Llc from India?

Aglagmed Llc sources from 1 verified Indian suppliers. The primary supplier is Arkray Healthcare Private Limited (100.0% of imports, $181.3K).

What is Aglagmed Llc's total pharmaceutical import value?

Aglagmed Llc's total pharmaceutical import value from India is $362.6K, based on 14 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Aglagmed Llc focus on?

Aglagmed Llc imports across 1 categories. The largest: Medical Devices & Diagnostics (100.0%).

Get Full Aglagmed Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.